Sulforaphane and Stomach Wellness Research

Summarize human and mechanistic research related to sulforaphane and stomach wellness. Focus on mucosal defense, oxidative stress, inflammatory markers, cellular defense pathways, and stomach/gut microbiology rather than H. pylori treatment claims.

Sulforaphane and Stomach Wellness

Executive summary

Sulforaphane has a clear mechanistic rationale for stomach-wellness research through mucosal oxidative and inflammatory stress-response pathways. Human evidence is smaller and mixed, relying largely on H. pylori-related indicators, pepsinogen, MDA, GSH, and other surrogate biomarkers.

Research flow

Cell studies suggest that sulforaphane can reduce ROS and stress-induced damage in gastric epithelial cells, while animal models connect its effects to Nrf2-dependent mucosal defense. Human research includes precision-grown broccoli food studies, precision-grown broccoli extract studies, adjunctive standard-therapy trials, and broccoli seed extract trials, but formats and endpoints vary.

Mechanism and markers

Sulforaphane reacts with Keap1 cysteine residues, stabilizes Nrf2, and supports transcription of HO-1, NQO1, GCLC/GCLM, and GST. Stomach-related markers include TNF-alpha, IL-1 beta, IL-8, pepsinogen I/II, PG I/PG II ratio, ROS, MDA, GSH, and SOD.

Human research summary

Some studies report temporary reductions in selected H. pylori-related or mucosal oxidative-stress markers. Others report limited or no group-level differences. The current evidence is best interpreted as biomarker and mucosal-defense context, not as a stomach-treatment conclusion.

Microbiology and safety

Most stomach microbiology work focuses on H. pylori. Broader gastric microbiome data are limited. Tolerability is generally acceptable, but concentrated preparations and high-dose contexts should not be interpreted as “more is always better.”